Carbidopa 50 MG / entacapone 200 MG / levodopa 200 MG Oral Tablet — RxCUI 730988
RxNorm drug concept · Semantic clinical drug
RxCUI 730988
Semantic clinical drug · SCD
● Current RxNorm concept 30 FDA products
48 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI730988
Official nameCarbidopa 50 MG / entacapone 200 MG / levodopa 200 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asCarbidopa 50 MG / entacapone 200 MG / L-DOPA 200 MG Oral Tablet
FDA products mapped30
Package NDCs mapped48
Reported Medicaid activity (SDUD)868 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Entacapone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Entacapone works by blocking an enzyme that breaks down levodopa in your body, but its effect only lasts a few hours. That's why you take one tablet with each levodopa dose — so it...
- Why do I have to take entacapone every time I take my levodopa? Can't I just take it once a day?
- That's actually a well-known and harmless side effect of entacapone — it can turn your urine an orange-brown color. It doesn't mean anything is wrong with your kidneys or liver. Th...
- My urine looks orange or brownish since I started entacapone. Should I be worried?
🕸️ Concept Web — How Carbidopa 50 MG / entacapone 200 MG / levodopa 2... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Carbidopa 50 MG / entacapone 200 MG / levodopa 200 MG Oral Tablet
RxCUI 730988 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Carbidopa
2019IN -
Entacapone
60307IN -
Levodopa
6375IN -
Carbidopa / entacapone / levodopa
404786MIN
-
Carbidopa
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Stalevo
1372713BN
-
Stalevo
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Carbidopa / entacapone / levodopa Oral Tablet
405915SCDF -
Carbidopa / entacapone / levodopa Oral Product
1156072SCDG -
Carbidopa / entacapone / levodopa Pill
1156073SCDG -
Carbidopa / entacapone / levodopa Oral Tablet [Stalevo]
406212SBDF -
Stalevo Oral Product
1178401SBDG -
Stalevo Pill
1177811SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Carbidopa / entacapone / levodopa Oral Tablet
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Carbidopa 50 MG
315569SCDC -
Entacapone 200 MG
330326SCDC -
Levodopa 200 MG
316142SCDC -
Carbidopa 50 MG / entacapone 200 MG / levodopa 200 MG Oral Tablet [Stalevo]
730992SBD -
Carbidopa 50 MG / entacapone 200 MG / levodopa 200 MG [Stalevo]
730990SBDC
-
Carbidopa 50 MG
Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Carbidopa 50 MG
SCDC · 315569 -
Entacapone 200 MG
SCDC · 330326 -
Levodopa 200 MG
SCDC · 316142 -
Carbidopa / entacapone / levodopa Oral Tablet
SCDF · 405915 -
Carbidopa / entacapone / levodopa Oral Product
SCDG · 1156072 -
Carbidopa / entacapone / levodopa Pill
SCDG · 1156073
Brand-Name Concepts
-
Carbidopa 50 MG / entacapone 200 MG / levodopa 200 MG Oral Tablet [Stalevo]
SBD · 730992 -
Carbidopa 50 MG / entacapone 200 MG / levodopa 200 MG [Stalevo]
SBDC · 730990 -
Carbidopa / entacapone / levodopa Oral Tablet [Stalevo]
SBDF · 406212 -
Stalevo Oral Product
SBDG · 1178401 -
Stalevo Pill
SBDG · 1177811 -
Stalevo
BN · 1372713
📦 FDA Products & Package NDCs
30 products · 48 package NDCs
48 package NDCs map to RxCUI 730988 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00781-5613-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0781-5613-01) | Carbidopa, Levodopa, and Entacapone | Sandoz Inc | 2014-06-18 |
| 00781-5625-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0781-5625-01) | Carbidopa, Levodopa, and Entacapone | Sandoz Inc | 2014-06-18 |
| 00781-5637-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0781-5637-01) | Carbidopa, Levodopa, and Entacapone | Sandoz Inc | 2014-06-18 |
| 00781-5641-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0781-5641-01) | Carbidopa, Levodopa, and Entacapone | Sandoz Inc | 2014-06-18 |
| 00781-5654-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0781-5654-01) | Carbidopa, Levodopa, and Entacapone | Sandoz Inc | 2014-06-18 |
| 00781-5669-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0781-5669-01) | Carbidopa, Levodopa, and Entacapone | Sandoz Inc | 2014-06-18 |
| 16571-0689-01 | 100 TABLET, FILM COATED in 1 BOTTLE (16571-689-01) | CARBIDOPA, LEVODOPA AND ENTACAPONE | Rising Pharma Holdings, Inc. | 2021-08-05 |
| 16571-0690-01 | 100 TABLET, FILM COATED in 1 BOTTLE (16571-690-01) | CARBIDOPA, LEVODOPA AND ENTACAPONE | Rising Pharma Holdings, Inc. | 2021-08-05 |
| 16571-0691-01 | 100 TABLET, FILM COATED in 1 BOTTLE (16571-691-01) | CARBIDOPA, LEVODOPA AND ENTACAPONE | Rising Pharma Holdings, Inc. | 2021-08-05 |
| 16571-0692-01 | 100 TABLET, FILM COATED in 1 BOTTLE (16571-692-01) | CARBIDOPA, LEVODOPA AND ENTACAPONE | Rising Pharma Holdings, Inc. | 2021-08-05 |
| 16571-0693-01 | 100 TABLET, FILM COATED in 1 BOTTLE (16571-693-01) | CARBIDOPA, LEVODOPA AND ENTACAPONE | Rising Pharma Holdings, Inc. | 2021-08-05 |
| 16571-0694-01 | 100 TABLET, FILM COATED in 1 BOTTLE (16571-694-01) | CARBIDOPA, LEVODOPA AND ENTACAPONE | Rising Pharma Holdings, Inc. | 2021-08-05 |
| 33342-0491-11 | 100 TABLET, FILM COATED in 1 BOTTLE (33342-491-11) | Carbidopa, Levodopa and Entacapone | Macleods Pharmaceuticals Limited | 2025-04-15 |
| 33342-0491-12 | 10 BLISTER PACK in 1 CARTON (33342-491-12) / 10 TABLET, FIL... | Carbidopa, Levodopa and Entacapone | Macleods Pharmaceuticals Limited | 2025-04-15 |
| 33342-0492-11 | 100 TABLET, FILM COATED in 1 BOTTLE (33342-492-11) | Carbidopa, Levodopa and Entacapone | Macleods Pharmaceuticals Limited | 2025-04-15 |
| 33342-0492-12 | 10 BLISTER PACK in 1 CARTON (33342-492-12) / 10 TABLET, FIL... | Carbidopa, Levodopa and Entacapone | Macleods Pharmaceuticals Limited | 2025-04-15 |
| 33342-0493-11 | 100 TABLET, FILM COATED in 1 BOTTLE (33342-493-11) | Carbidopa, Levodopa and Entacapone | Macleods Pharmaceuticals Limited | 2025-04-15 |
| 33342-0493-12 | 10 BLISTER PACK in 1 CARTON (33342-493-12) / 10 TABLET, FIL... | Carbidopa, Levodopa and Entacapone | Macleods Pharmaceuticals Limited | 2025-04-15 |
| 33342-0494-11 | 100 TABLET, FILM COATED in 1 BOTTLE (33342-494-11) | Carbidopa, Levodopa and Entacapone | Macleods Pharmaceuticals Limited | 2025-04-15 |
| 33342-0494-12 | 10 BLISTER PACK in 1 CARTON (33342-494-12) / 10 TABLET, FIL... | Carbidopa, Levodopa and Entacapone | Macleods Pharmaceuticals Limited | 2025-04-15 |
| 33342-0495-11 | 100 TABLET, FILM COATED in 1 BOTTLE (33342-495-11) | Carbidopa, Levodopa and Entacapone | Macleods Pharmaceuticals Limited | 2025-04-15 |
| 33342-0495-12 | 10 BLISTER PACK in 1 CARTON (33342-495-12) / 10 TABLET, FIL... | Carbidopa, Levodopa and Entacapone | Macleods Pharmaceuticals Limited | 2025-04-15 |
| 33342-0496-11 | 100 TABLET, FILM COATED in 1 BOTTLE (33342-496-11) | Carbidopa, Levodopa and Entacapone | Macleods Pharmaceuticals Limited | 2025-04-15 |
| 33342-0496-12 | 10 BLISTER PACK in 1 CARTON (33342-496-12) / 10 TABLET, FIL... | Carbidopa, Levodopa and Entacapone | Macleods Pharmaceuticals Limited | 2025-04-15 |
| 46708-0795-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-795-31) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Limited | 2026-02-12 |
| 46708-0795-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-795-91) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Limited | 2026-02-12 |
| 46708-0796-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-796-31) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Limited | 2026-02-12 |
| 46708-0796-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-796-91) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Limited | 2026-02-12 |
| 46708-0797-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-797-31) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Limited | 2026-02-12 |
| 46708-0797-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-797-91) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Limited | 2026-02-12 |
| 46708-0798-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-798-31) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Limited | 2026-02-12 |
| 46708-0798-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-798-91) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Limited | 2026-02-12 |
| 46708-0799-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-799-31) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Limited | 2026-02-12 |
| 46708-0799-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-799-91) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Limited | 2026-02-12 |
| 46708-0800-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-800-31) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Limited | 2026-02-12 |
| 46708-0800-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-800-91) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Limited | 2026-02-12 |
| 62332-0795-31 | 100 TABLET, FILM COATED in 1 BOTTLE (62332-795-31) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Inc. | 2026-02-12 |
| 62332-0795-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-795-91) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Inc. | 2026-02-12 |
| 62332-0796-31 | 100 TABLET, FILM COATED in 1 BOTTLE (62332-796-31) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Inc. | 2026-02-12 |
| 62332-0796-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-796-91) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Inc. | 2026-02-12 |
| 62332-0797-31 | 100 TABLET, FILM COATED in 1 BOTTLE (62332-797-31) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Inc. | 2026-02-12 |
| 62332-0797-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-797-91) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Inc. | 2026-02-12 |
| 62332-0798-31 | 100 TABLET, FILM COATED in 1 BOTTLE (62332-798-31) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Inc. | 2026-02-12 |
| 62332-0798-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-798-91) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Inc. | 2026-02-12 |
| 62332-0799-31 | 100 TABLET, FILM COATED in 1 BOTTLE (62332-799-31) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Inc. | 2026-02-12 |
| 62332-0799-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-799-91) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Inc. | 2026-02-12 |
| 62332-0800-31 | 100 TABLET, FILM COATED in 1 BOTTLE (62332-800-31) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Inc. | 2026-02-12 |
| 62332-0800-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-800-91) | carbidopa, levodopa and entacapone | Alembic Pharmaceuticals Inc. | 2026-02-12 |
Observed labelers:
Alembic Pharmaceuticals Inc. (12) ·
Alembic Pharmaceuticals Limited (12) ·
Macleods Pharmaceuticals Limited (12) ·
Rising Pharma Holdings, Inc. (6) ·
Sandoz Inc (6)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.